Biotech
DEERFIELD, IL: DEERFIELD, IL -- (Marketwire) -- 03/04/13 -- Horizon Pharma, Inc. (NASDAQ: HZNP) announced today that its fourth quarter and year ended December 31, 2012 financial results will be released on Monday, ...
BEVERLY, MA: BEVERLY, MA -- (Marketwire) -- 03/04/13 -- Cellceutix Corporation (OTCBB: CTIX) (the "Company"), a clinical stage biopharmaceutical company focused on discovering small molecule drugs to tr ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwire) -- 03/01/13 -- EntreMed, Inc. (NASDAQ: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it ha ...
BERKELEY, CA: BERKELEY, CA -- (Marketwire) -- 03/01/13 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today reported financial results for the fourth quarter and year ended December 31, 2012. The Company had $ ...
NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 03/01/13 -- Immunovative, Inc. (OTCQB: IMUN) ("Immunovative"), Immunovative Therapies, Ltd. ("ITL"), and Dr. Michael Har-Noy, CEO of ITL, announce ...
NEW YORK, NY: Phase II Results in Metastatic Breast Cancer Expected in Mid-2013; Report Cites Eniluracil Market Potential of $310 to $465 Million per Year; Available for Download at www.lifesciadvisors.com/clients/ ...
RALEIGH, NC: RALEIGH, NC -- (Marketwire) -- 03/01/13 -- DARA BioSciences, Inc. (NASDAQ: DARA) (the "Company" or "DARA"), announced today the appointments of Haywood D. Cochrane Jr. as chairman ...
SAN FRANCISCO, CA: $57.4 Million in Fourth Quarter Net Sales Reflect First Full Quarter of XTANDI Sales; Conference Call Today at 4:30 p.m. Eastern Time ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 02/28/13 -- Alethia Biotherapeutics Inc., a privately held biotechnology company focusing on the development of therapeutic monoclonal antibodies, announced today ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 02/28/13 -- Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, today announced that it has received regulatory approval from the T ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 02/28/13 -- Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, today reported its financial results for the fourth quarter and yea ...
BRISBANE, AUSTRALIA: BRISBANE, AUSTRALIA -- (Marketwire) -- 02/28/13 --415 patients recruited; recruitment now closedParticipation in sub-study outperformed expectationsResults expected early 2014Brisbane drug discovery a ...
TORONTO, ONTARIO and LONDON, ONTARIO: TORONTO, ONTARIO and LONDON, ONTARIO -- (Marketwire) -- 02/28/13 -- The Centre for Commercialization of Regenerative Medicine (CCRM) is pleased to announce the addition of Sernova Corp. ("Sernov ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwire) -- 02/27/13 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (ISIN: US74154B2034) ("Prima," the "Company") is pleased to announce that it has commen ...
WINNIPEG, MANITOBA: Over 80 Pharmacies Preparing for Expanded Consumer Testing Across Canada ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 02/27/13 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the period ended November 30, 2012.Fiscal 2012 Highligh ...
TUSTIN, CA: TUSTIN, CA -- (Marketwire) -- 02/26/13 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a biopharmaceutical company developing first-in-class monoclonal antibodies focused on the treatment and diag ...
TUSTIN, CA and HUNTINGTON BEACH, CA: Solutions to Increase Lifetime of Purifications Resins to Decrease Production Costs; Successful Utilization of a Quality by Design (QbD) Approach to Identify Critical Process Parameters That Control C ...
EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA: EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA -- (Marketwire) -- 02/26/13 -- Sunshine Heart, Inc. (NASDAQ: SSH) (ASX: SHC) today announced that the company is scheduled to attend the following upcoming inve ...
SAN DIEGO, CA: Validated Preclinical Technology to Be Used for Non-Toxic Treatment of Breast Cancer and Melanoma ...
